Search results for "Weight Loss Injection"

The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack

The Unexpected Heart Benefits of Weight Loss Injections: Reducing Complications After Heart Attack

New research indicates that the class of drugs used in popular weight loss injections may do more than shed pounds; they could lower the risk of...
'10kg Weight Loss' Pani Bottle, Yo-Yo After Stopping Wegovy

'10kg Weight Loss' Pani Bottle, Yo-Yo After Stopping Wegovy

Travel YouTuber Pani Bottle confessed to experiencing a yo-yo effect. Pani Bottle recently posted a photo taken during his travels on his social...
Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound

Losing Weight Fast on Wegovy or Mounjaro? How High-Protein Foods Prevent Rebound

Popular anti-obesity injections like Wegovy and Mounjaro reduce appetite and prolong feelings of fullness.
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
'A Hellish Time': Chronic Ear Disorder Forces IU to Postpone Concert Tour and Album Release

'A Hellish Time': Chronic Ear Disorder Forces IU to Postpone Concert Tour and Album Release

Singer and actor IU, 33, has postponed her upcoming September concert tour and the release of her sixth full-length...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven

Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...
Beyond the Quick Fix: Why Chronic Steroid Misuse Risks Bone Loss and Facial Flushing

Beyond the Quick Fix: Why Chronic Steroid Misuse Risks Bone Loss and Facial Flushing

Whenever a medication is prescribed or administered, understanding its potential side effects is a vital safety measure.
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.
HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N’s Obesity Drug Candidate Outperforms Wegovy in Head-to-Head Phase 2 Trial

HK inno.N announced on June 9 that its obesity drug candidate, ecnoglutide, demonstrated superior weight-loss efficacy...